Common use of Proposal of Targets Clause in Contracts

Proposal of Targets. Following Lexicon's completion of ▇▇▇▇▇ ▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ of a line of Mutant Mice corresponding to a Target [**], BMS and Lexicon shall each have the right to propose such Target for inclusion in the Research Program as a Selected Target. Within [**] following the proposal by either party that such Proposed Target be considered for designation as a Selected Target [**], BMS and Lexicon shall provide the Joint Scientific Committee with the following information: (a) all relevant scientific data in BMS's possession (and which BMS has the right to disclose to Lexicon) and all relevant scientific data in Lexicon's possession (and which Lexicon has the right to disclose to BMS) relating specifically to such Proposed Target, including, without limitation, any bioinformatics and expression analyses conducted by BMS or Lexicon with respect to such Proposed Target, and any phenotypic data with respect to mice (including, without limitation, Mutant Mice) with a mutation in the murine ortholog of such Proposed Target; (b) the results of genomic analysis and druggability assessment with respect to such Proposed Target by BMS and/or Lexicon; (c) whether (and, if so, to what extent) such Proposed Target is [**]; and (d) whether BMS or Lexicon, respectively, has [**] and, in the event BMS or Lexicon, respectively, has [**], such party shall [**].

Proposal of Targets. Following Lexicon's completion of ▇▇▇▇Level 2 Phenotypic Analysis of a line of Mutant Mice corresponding t▇ ▇ ▇▇▇▇▇▇▇▇ [**], ▇▇▇ ▇▇▇ ▇▇▇▇▇▇ of a line of Mutant Mice corresponding to a Target [**], BMS and Lexicon xicon shall each have the right to propose such Target for inclusion in the Research Program as a Selected Target. Within [**] following the proposal by either party that such Proposed Target be considered for designation as a Selected Target [**], BMS and Lexicon shall provide the Joint Scientific Committee with the following information: (a) all relevant scientific data in BMS's possession (and which BMS has the right to disclose to Lexicon) and all relevant scientific data in Lexicon's possession (and which Lexicon has the right to disclose to BMS) relating specifically to such Proposed Target, including, without limitation, any bioinformatics and expression analyses conducted by BMS or Lexicon with respect to such Proposed Target, and any phenotypic data with respect to mice (including, without limitation, Mutant Mice) with a mutation in the murine ortholog of such Proposed Target; (b) the results of genomic analysis and druggability assessment with respect to such Proposed Target by BMS and/or Lexicon; (c) whether (and, if so, to what extent) such Proposed Target is [**]; and (d) whether BMS or Lexicon, respectively, has [**] and, in the event BMS or Lexicon, respectively, has [**], such party shall [**].